Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.

W Insull; M Koren; J Davignon; D Sprecher; H Schrott; L M Keilson; A S Brown; C A Dujovne; M H Davidson; R McLain

doi:10.1016/s0021-9150(00)00615-8

Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.

Identifier:nobleid.org/w1/20260515/2D5EB7DA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2D5EB7DA.svg?ark=w1%2F20260515%2F2D5EB7DA)](https://nobleid.org/work/w1/20260515/2D5EB7DA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.

Identifier:nobleid.org/w1/20260515/2D5EB7DA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2D5EB7DA.svg?ark=w1%2F20260515%2F2D5EB7DA)](https://nobleid.org/work/w1/20260515/2D5EB7DA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work